Supplementary Figure 7 from Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways

Authors :: Mohamed El-Tanani
Philip S. Rudland
Patrick G. Johnston
Dean A. Fennell
Pasi Janne
Ken O'Byrne
Osama Sharaf Eldin
Angela Platt-Higgins
James T. Murray
Claire Grills
Ka-Kui Chan
Hiu-Fung Yuen
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 3.6K, Cancer cells with K-Ras activation mutation (HCT116/Hkh-2 isogenic pair) are more susceptible to Ran silencing-induced apoptosis.

Tools